Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 90%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
39,706
Total Claims
$1.2M
Drug Cost
879
Beneficiaries
$1,332
Cost/Patient
Risk Score Breakdown 36/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,961 Nephrology providers
+4%
Cost per patient vs peers
$1,332 vs $1,283 avg
-3%
Brand preference vs peers
8.6% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.9%
Opioid Rate
347
Opioid Claims
$9,979
Opioid Cost
19.0%
Long-Acting Rate
Brand vs Generic
Brand: 3,426 claims · $754K
Generic: 36,187 claims · $413K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 756 | $144K |
| Sitagliptin Phosphate | 95 | $42K |
| Semaglutide | 32 | $37K |
| Sitagliptin Phos/Metformin Hcl | 102 | $37K |
| Dapagliflozin Propanediol | 68 | $33K |
| Linagliptin | 157 | $33K |
| Rivaroxaban | 211 | $32K |
| Empagliflozin | 104 | $31K |
| Mirabegron | 123 | $20K |
| Linaclotide | 29 | $18K |
| Fluticasone/Umeclidin/Vilanter | 24 | $18K |
| Atorvastatin Calcium | 2,446 | $16K |
| Tiotropium Bromide | 21 | $15K |
| Naloxegol Oxalate | 25 | $15K |
| Fluticasone/Vilanterol | 30 | $13K |
Prescribing Profile
Patient Profile
80
Avg Age
60%
Female
1.31
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About